KidneyIntelX
Bringing Precision Medicine to Kidney Care in Patients with Type 2 Diabetes
One in five adults with early diabetic kidney disease will progress toward kidney failure. Unfortunately, traditional clinical tools are unable to differentiate who is at low risk and who is at high risk.
KidneyIntelX is a new diagnostic tool that assesses a patient’s risk-level for progressive kidney function decline with 90% accuracy. By providing a personalized risk score, KidneyIntelX empowers physicians and patients to work together to design a care plan that meets their individual needs.
The KidneyIntelX™ Test
KidneyIntelX is an in vitro diagnostic that assesses the risk of adverse kidney outcomes in patients with type 2 diabetes and early-stage kidney disease. This simple test is performed as a standard blood draw and can be easily incorporated into your regular care plan and office visit workflow.
KidneyIntelX provides actionable insights through a unique patient risk score that indicates the near-term risk of kidney function decline or failure that can be linked to specific guideline-driven clinical actions.
Maintain
Low
Low risk patients are not likely to rapidly progress to end stage kidney disease and should continue to be monitored by their doctor every year
Monitor
Intermediate
Intermediate risk patients require more primary care follow up (two to three times per year) and may need a referral to a specialist
ACT
High
High risk patients are significantly more likely to progress to end stage kidney disease and require more aggressive care, potentially including a referral to a specialist
Our Clinical Studies Demonstrate the Powerful Predictive Value of KidneyIntelX
A patient with high KidneyIntelX risk score is 7 times more likely to experience RKFD or kidney failure than a patient scoring low. Read our clinical studies and publications to learn more about the powerful predictive value of KidneyIntelX.